VISUDYNE Side Effects

7006191-0 | Choroidal Neovascularisation, Visual Acuity Reduced
on Sep 03, 2010 Female patient from SPAIN , child 8 years of age, was diagnosed with choroidal neovascularisation and was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: choroidal neovascularisation, visual acuity reduced. Visudyne dosage: 6 Mg/m^2 Daily Iv.

7005241-5 | Macular Hole, Retinal Oedema, Visual Acuity Reduced
Patient was taking Visudyne (View Usage). Patient had the following side effects: macular hole, retinal oedema, visual acuity reduced on Sep 03, 2010 from LEBANON Additional patient health information: Female patient , 66 years of age, was diagnosed with choroidal neovascularisation and. Visudyne dosage: .

7003485-X | Cerebellar Infarction, Incontinence, Lacunar Infarction
Adverse event was reported on Sep 03, 2010 by a Male patient taking Visudyne (View Usage) (Dosage: ) . Location: JAPAN , 81 years of age, After Visudyne was administered, patient had the following side effects: cerebellar infarction, incontinence, lacunar infarction. During the same period patient was treated with LUCENTIS (0.05 Ml Daily Ey) (View Lucentis Review and Lucentis Label ), MOXIFLOXACIN HYDROCHLORIDE (View Moxifloxacin Hydrochloride Review and Moxifloxacin Hydrochloride Label ), RINDERON (View Rinderon Review and Rinderon Label ), SOLANTAL (View Solantal Review and Solantal Label ). Patient was hospitalized.

6986132-2 | Retinal Tear
on Aug 26, 2010 Male patient from JAPAN , 67 years of age, was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: retinal tear. Visudyne dosage: .


6939470-3 | Cystitis
on Aug 03, 2010 Female patient from JAPAN , 85 years of age, was treated with Visudyne (View Usage). Patient had the following side effects: cystitis. Visudyne dosage: 6 Mg/m^2 Once Iv. Patient was hospitalized.

6936704-6 | Cystitis
Patient was taking Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: cystitis on Aug 03, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, weighting 121.3 lb, . Visudyne dosage: 4.8 Ml Once Iv. Patient was hospitalized.

6936388-7 | Retinal Scar, Scotoma, Visual Acuity Reduced
Adverse event was reported on Aug 05, 2010 by a Female patient taking Visudyne (View Usage) (Dosage: 15 Mg Daily Iv) . Location: UNITED STATES , 88 years of age, Patient experienced the following unwanted or unexpected effects: retinal scar, scotoma, visual acuity reduced.

6925031-9 | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Hepatic Function Abnormal, Renal Impairment
on Jul 28, 2010 Male patient from JAPAN , 63 years of age, was treated with Visudyne (View Usage). Patient had the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, hepatic function abnormal, renal impairment. Visudyne dosage: . Patient was hospitalized.

6919580-7 | Retinal Oedema, Visual Acuity Reduced, Vitreous Detachment
on Jul 22, 2010 Female patient from AUSTRALIA , 17 years of age, was diagnosed with hamartoma and was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: retinal oedema, visual acuity reduced, vitreous detachment. Visudyne dosage: .

6831728-1 | Eye Irritation, Retinal Oedema, Visual Acuity Reduced
Patient was taking Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: eye irritation, retinal oedema, visual acuity reduced on Jun 21, 2010 from TURKEY Additional patient health information: Female patient , 56 years of age, was diagnosed with choroidal neovascularisation and. Visudyne dosage: 5.25 Ml Once Iv. During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

6828684-9 | Eye Irritation, Eye Pain, Retinal Oedema, Visual Acuity Reduced
Adverse event was reported on Jun 21, 2010 by a Female patient taking Visudyne (View Usage) (Dosage: 5.25 Ml Once Iv) was diagnosed with choroidal neovascularisation and. Location: TURKEY , 56 years of age, Patient had the following side effects: eye irritation, eye pain, retinal oedema, visual acuity reduced. During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

6821206-8 | Off Label Use, Tumour Haemorrhage, Visual Acuity Reduced, Vitreous Haemorrhage
on Jun 18, 2010 Male patient from AUSTRALIA , 56 years of age, weighting 185.2 lb, was diagnosed with choroid melanoma and was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: off label use, tumour haemorrhage, visual acuity reduced, vitreous haemorrhage. Visudyne dosage: 6 Ml Once Iv.

6821205-6 | Off Label Use, Visual Acuity Reduced, Vitreous Haemorrhage
on Jun 18, 2010 Female patient from AUSTRALIA , 66 years of age, weighting 258.0 lb, was diagnosed with choroid melanoma and was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, visual acuity reduced, vitreous haemorrhage. Visudyne dosage: 6.6 Ml Once Iv.

6814676-2 | Eye Laser Scar, Maculopathy, Scotoma, Visual Acuity Reduced
Patient was taking Visudyne (View Usage). Patient had the following side effects: eye laser scar, maculopathy, scotoma, visual acuity reduced on Jun 21, 2010 from UNITED STATES Additional patient health information: Female patient , 88 years of age, . Visudyne dosage: 15 Mg Daily Iv.

6796390-5 | Gastrointestinal Haemorrhage, Peritonitis, Procedural Complication
Adverse event was reported on Jun 09, 2010 by a Female patient taking Visudyne (View Usage) (Dosage: ) . Location: JAPAN , 84 years of age, After Visudyne was administered, patient had the following side effects: gastrointestinal haemorrhage, peritonitis, procedural complication. During the same period patient was treated with LUCENTIS (0.05 Ml Once Ey) (View Lucentis Review and Lucentis Label ), CRAVIT (View Cravit Review and Cravit Label ). Patient was hospitalized.

6785108-8 | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Hepatic Function Abnormal, Renal Impairment
on Jun 04, 2010 Male patient from JAPAN , 63 years of age, was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, hepatic function abnormal, renal impairment. Visudyne dosage: . Patient was hospitalized.

6766626-5 | Eye Irritation, Eye Pain, Retinal Detachment
on May 26, 2010 Female patient from TURKEY , 56 years of age, was treated with Visudyne (View Usage). Patient had the following side effects: eye irritation, eye pain, retinal detachment. Visudyne dosage: 5.25 Ml Once Iv. During the same period patient was treated with BENVACIZUMAB (View Benvacizumab Review and Benvacizumab Label ).

6766611-3 | Detachment Of Retinal Pigment Epithelium, Metamorphopsia, Vision Blurred
Patient was taking Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: detachment of retinal pigment epithelium, metamorphopsia, vision blurred on Jun 01, 2010 from ITALY Additional patient health information: Female patient , 86 years of age, was diagnosed with choroidal neovascularisation and. Visudyne dosage: . During the same period patient was treated with KENALOG (4 Mg Once Ey) (View Kenalog Review and Kenalog Label ).

6763934-9 | Iatrogenic Injury
Adverse event was reported on May 28, 2010 by a Female patient taking Visudyne (View Usage) (Dosage: 15 Mg Daily Iv) . Location: UNITED STATES , 88 years of age, Patient experienced the following unwanted or unexpected effects: iatrogenic injury.

6759698-5 | Retinal Oedema, Visual Acuity Reduced
on May 20, 2010 Female patient from TURKEY , 75 years of age, was treated with Visudyne (View Usage). Patient had the following side effects: retinal oedema, visual acuity reduced. Visudyne dosage: . During the same period patient was treated with ALTUZAN (View Altuzan Review and Altuzan Label ).

6755558-4 | Retinal Detachment, Retinal Infarction, Retinal Tear, Vitreous Haemorrhage
on May 18, 2010 Female patient from ITALY , 86 years of age, was diagnosed with choroidal neovascularisation and was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: retinal detachment, retinal infarction, retinal tear, vitreous haemorrhage. Visudyne dosage: . During the same period patient was treated with KENALOG (View Kenalog Review and Kenalog Label ).

6755540-7 | Arthralgia, Headache, Off Label Use
Patient was taking Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, headache (What is headache?), off label use on May 17, 2010 from SLOVENIA Additional patient health information: Male patient , 36 years of age, was diagnosed with haemangioma and. Visudyne dosage: .

6754148-7 | Alanine Aminotransferase Increased, Alcoholic, Aspartate Aminotransferase Increased, Back Pain, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Chills, Gamma-glutamyltransferase Increased
Adverse event was reported on May 14, 2010 by a Male patient taking Visudyne (View Usage) (Dosage: ) was diagnosed with polypoidal choroidal vasculopathy and. Location: JAPAN , 55 years of age, weighting 159.6 lb, Patient had the following side effects: alanine aminotransferase increased, alcoholic, aspartate aminotransferase increased, back pain (What is back pain?), blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, chills, gamma-glutamyltransferase increased. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6752752-3 | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Hepatic Function Abnormal, Renal Impairment
on May 13, 2010 Male patient from JAPAN , 56 years of age, was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, hepatic function abnormal, renal impairment. Visudyne dosage: . Patient was hospitalized.

6752713-4 | Macular Oedema, Visual Acuity Reduced, Visual Field Defect
on May 21, 2010 Female patient from UNITED STATES , 82 years of age, weighting 134.0 lb, was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: macular oedema, visual acuity reduced, visual field defect. Visudyne dosage: 9.6 Mg Daily Iv. During the same period patient was treated with AVASTIN (1.25 Mg Daily Ey) (View Avastin Review and Avastin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), NORVASC (View Norvasc Review and Norvasc Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), VITAMIN C (View Vitamin C Review and Vitamin C Label ).

6750460-6 | Macular Oedema, Retinal Exudates, Retinal Haemorrhage, Retinal Oedema
Patient was taking Visudyne (View Usage). Patient had the following side effects: macular oedema, retinal exudates, retinal haemorrhage, retinal oedema on May 11, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 16 years of age, was diagnosed with haemangioma of retina and. Visudyne dosage: .

6730187-7 | Retinal Oedema, Visual Acuity Reduced
Adverse event was reported on Apr 30, 2010 by a Female patient taking Visudyne (View Usage) (Dosage: 9.6 Mg Daily Iv) . Location: UNITED STATES , 82 years of age, weighting 134.0 lb, After Visudyne was administered, patient had the following side effects: retinal oedema, visual acuity reduced. During the same period patient was treated with AVASTIN (1.25 Mg, Daily Ey) (View Avastin Review and Avastin Label ).

6722201-X | Arthralgia, Headache, Off Label Use
on Apr 22, 2010 Male patient from SLOVENIA , 36 years of age, was diagnosed with chorioretinal disorder, haemangioma and was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, headache (What is headache?), off label use. Visudyne dosage: .

6680273-5 | Corneal Scar, Extravasation, Eye Disorder, Glaucoma, Off Label Use, Retinal Haemorrhage, Retinal Ischaemia, Retinal Oedema, Visual Acuity Reduced
on Mar 25, 2010 Female patient from POLAND , 75 years of age, weighting 149.9 lb, was treated with Visudyne (View Usage). Patient had the following side effects: corneal scar, extravasation, eye disorder, glaucoma (What is glaucoma?), off label use, retinal haemorrhage, retinal ischaemia, retinal oedema, visual acuity reduced. Visudyne dosage: 5.1 Ml Once Iv. During the same period patient was treated with FLUORESCEIN SODIUM (View Fluorescein Sodium Review and Fluorescein Sodium Label ), TRUSOPT (View Trusopt Review and Trusopt Label ), POSORUTIN (View Posorutin Review and Posorutin Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized.

6669787-1 | Cystitis
Patient was taking Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: cystitis on Mar 16, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, . Visudyne dosage: 6 Mg/m^2 Once Iv. Patient was hospitalized.

6659918-1 | Off Label Use, Optic Nerve Disorder, Retinal Haemorrhage, Retinal Ischaemia, Retinal Oedema, Visual Acuity Reduced
Adverse event was reported on Mar 11, 2010 by a Female patient taking Visudyne (View Usage) (Dosage: 5.1 Ml Once Iv) . Location: POLAND , 75 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: off label use, optic nerve disorder, retinal haemorrhage, retinal ischaemia, retinal oedema, visual acuity reduced. During the same period patient was treated with FLUORESCEIN SODIUM (View Fluorescein Sodium Review and Fluorescein Sodium Label ), TRUSOPT (View Trusopt Review and Trusopt Label ), POSORUTIN (View Posorutin Review and Posorutin Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized.

6647860-1 | Polypoidal Choroidal Vasculopathy, Retinal Oedema, Retinal Vein Occlusion, Visual Acuity Reduced
on Mar 03, 2010 Male patient from JAPAN , 60 years of age, was treated with Visudyne (View Usage). Patient had the following side effects: polypoidal choroidal vasculopathy, retinal oedema, retinal vein occlusion, visual acuity reduced. Visudyne dosage: .

6643906-5 | Condition Aggravated, Nail Discolouration, Psoriasis, Skin Exfoliation
on Mar 02, 2010 Male patient from CHINA , 40 years of age, was diagnosed with chorioretinopathy and was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: condition aggravated, nail discolouration, psoriasis, skin exfoliation. Visudyne dosage: .

6637423-6 | Diplopia, Maculopathy
Patient was taking Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: diplopia, maculopathy on Mar 02, 2010 from SPAIN Additional patient health information: Female patient , 79 years of age, . Visudyne dosage: . During the same period patient was treated with LUCENTIS (View Lucentis Review and Lucentis Label ).

6589561-4 | Condition Aggravated, Retinal Oedema, Visual Acuity Reduced
Adverse event was reported on Feb 04, 2010 by a Female patient taking Visudyne (View Usage) (Dosage: 6 Mg/m^2 Once Iv) was diagnosed with haemangioma, retinal disorder (What is retinal disorder?) and. Location: KOREA, REPUBLIC OF , 15 years of age, Patient had the following side effects: condition aggravated, retinal oedema, visual acuity reduced.

6552859-X | Condition Aggravated, Eye Oedema, Vision Blurred, Visual Acuity Reduced
on Jan 20, 2010 Female patient from FRANCE , 83 years of age, weighting 114.7 lb, was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: condition aggravated, eye oedema, vision blurred, visual acuity reduced. Visudyne dosage: . During the same period patient was treated with FLUORESCEIN (View Fluorescein Review and Fluorescein Label ), AMLOR (View Amlor Review and Amlor Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), SOTALEX (View Sotalex Review and Sotalex Label ).

6551923-9 | Condition Aggravated, Eye Oedema, Vision Blurred, Visual Acuity Reduced
on Jan 05, 2010 Female patient from FRANCE , 83 years of age, weighting 114.7 lb, was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, eye oedema, vision blurred, visual acuity reduced. Visudyne dosage: . During the same period patient was treated with FLUORESCEIN (View Fluorescein Review and Fluorescein Label ), AMLOR (View Amlor Review and Amlor Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), SOTALEX (View Sotalex Review and Sotalex Label ).

6529007-5 | Loss Of Consciousness, Myocardial Infarction
Patient was taking Visudyne (View Usage). Patient had the following side effects: loss of consciousness, myocardial infarction on Dec 10, 2009 from JAPAN Additional patient health information: Female patient , 74 years of age, weighting 90.40 lb, . Visudyne dosage: 6 Mg/m^2 Once Iv. During the same period patient was treated with LUCENTIS (0.05 Ml Once Ey) (View Lucentis Review and Lucentis Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), TAKEPRON (View Takepron Review and Takepron Label ), LASIX (View Lasix Review and Lasix Label ), PANTOSIN (View Pantosin Review and Pantosin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), BENZALIN (View Benzalin Review and Benzalin Label ).

6523569-X | Asterixis, Convulsion, Dyskinesia, Myoclonus
Adverse event was reported on Dec 07, 2009 by a Male patient taking Visudyne (View Usage) (Dosage: 10.2 Mg Daily Iv) . Location: JAPAN , 73 years of age, After Visudyne was administered, patient had the following side effects: asterixis, convulsion, dyskinesia, myoclonus. During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), EBASTINE (View Ebastine Review and Ebastine Label ), ALLOZYM (View Allozym Review and Allozym Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), VESICARE (View Vesicare Review and Vesicare Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), DORNALIN (View Dornalin Review and Dornalin Label ).

6509536-0 | Convulsion
on Dec 02, 2009 Male patient from JAPAN , 73 years of age, was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Visudyne dosage: 10.2 Mg Daily Iv.

6502042-9 | Cerebrovascular Accident, Convulsion, Parkinson's Disease, Transient Ischaemic Attack, Tremor
on Nov 26, 2009 Male patient from JAPAN , 73 years of age, was treated with Visudyne (View Usage). Patient had the following side effects: cerebrovascular accident, convulsion, parkinson's disease (What is parkinson's disease?), transient ischaemic attack, tremor. Visudyne dosage: 10.2 Mg Daily Iv.

6467976-2 | Disease Progression, Retinal Artery Occlusion, Retinal Infarction, Retinal Oedema, Retinal Vein Occlusion, Visual Acuity Reduced
Patient was taking Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: disease progression, retinal artery occlusion, retinal infarction, retinal oedema, retinal vein occlusion, visual acuity reduced on Nov 09, 2009 from JAPAN Additional patient health information: Male patient , 60 years of age, . Visudyne dosage: .

6457440-9 | Gastrointestinal Haemorrhage, Melaena, Peritonitis
Adverse event was reported on Nov 05, 2009 by a Female patient taking Visudyne (View Usage) (Dosage: ) . Location: JAPAN , 84 years of age, Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, melaena, peritonitis. During the same period patient was treated with LUCENTIS (View Lucentis Review and Lucentis Label ). Patient was hospitalized.

6446518-1 | Arrhythmia
on Nov 02, 2009 Female patient from UNITED STATES , 62 years of age, was treated with Visudyne (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?). Visudyne dosage: . During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALTACE (View Altace Review and Altace Label ), CRESTOR (View Crestor Review and Crestor Label ).

6426173-7 | Caesarean Section
on Oct 15, 2009 Female patient from CHINA , 28 years of age, was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: caesarean section. Visudyne dosage: .

6413538-2 | Amnesia
Patient was taking Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia on Oct 05, 2009 from FRANCE Additional patient health information: Female patient , 79 years of age, . Visudyne dosage: . During the same period patient was treated with ODRIK (View Odrik Review and Odrik Label ), DIOSMINE (View Diosmine Review and Diosmine Label ), AZOPT (View Azopt Review and Azopt Label ), XALATAN (View Xalatan Review and Xalatan Label ).

6411207-6 | Myocardial Infarction
Adverse event was reported on Oct 05, 2009 by a Female patient taking Visudyne (View Usage) (Dosage: 6 Mg/m^2 Once Iv) . Location: JAPAN , 74 years of age, weighting 90.40 lb, Patient had the following side effects: myocardial infarction. During the same period patient was treated with LUCENTIS (0.05 Ml Once Ey) (View Lucentis Review and Lucentis Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6406959-5 | Eye Oedema, Vision Blurred, Visual Acuity Reduced
on Sep 29, 2009 Female patient from FRANCE , 83 years of age, was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: eye oedema, vision blurred, visual acuity reduced. Visudyne dosage: . During the same period patient was treated with FLUORESCEIN (View Fluorescein Review and Fluorescein Label ).

6399198-8 | Atrioventricular Block, Blood Pressure Increased, Hyperhidrosis, Pericarditis Constrictive
on Sep 23, 2009 Male patient from FRANCE , 57 years of age, was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block, blood pressure increased, hyperhidrosis, pericarditis constrictive. Visudyne dosage: 15 Mg Daily Iv. Patient was hospitalized.

6355682-4 | Dacryostenosis Acquired, Lacrimation Increased
Patient was taking Visudyne (View Usage). Patient had the following side effects: dacryostenosis acquired, lacrimation increased on Aug 27, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 80 years of age, . Visudyne dosage: .